PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 2932484

  • 1. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H.
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone suppression test combined with total sleep deprivation in depressed patients.
    Kasper S, Moises HW, Beckmann H.
    Psychiatr Clin (Basel); 1983 Sep; 16(1):17-25. PubMed ID: 6844658
    [Abstract] [Full Text] [Related]

  • 3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW, Wilens TE, Baldessarini RJ.
    Psychoneuroendocrinology; 1985 Sep; 10(1):49-60. PubMed ID: 4001277
    [Abstract] [Full Text] [Related]

  • 4. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I, Pottash AL, Gold MS.
    Psychoneuroendocrinology; 1985 Sep; 10(3):281-8. PubMed ID: 4059475
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 6. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J.
    J Affect Disord; 1987 Mar; 12(3):219-21. PubMed ID: 2956306
    [Abstract] [Full Text] [Related]

  • 7. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [Abstract] [Full Text] [Related]

  • 8. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
    Lee MA, Taylor MA.
    Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
    [Abstract] [Full Text] [Related]

  • 9. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
    Psychoneuroendocrinology; 1986 Oct; 11(1):117-20. PubMed ID: 3704065
    [Abstract] [Full Text] [Related]

  • 10. Association performance and the DST.
    Demeter E, Rihmer Z, Arato M, Frecska E.
    Psychiatry Res; 1986 Jul; 18(3):289-90. PubMed ID: 3749388
    [No Abstract] [Full Text] [Related]

  • 11. Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients.
    Halbreich U, Olympia J, Carson S, Glogowski J, Yeh CM, Axelrod S, Desu MM.
    Psychoneuroendocrinology; 1989 Jul; 14(5):365-70. PubMed ID: 2813658
    [Abstract] [Full Text] [Related]

  • 12. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [Abstract] [Full Text] [Related]

  • 13. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK.
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract] [Full Text] [Related]

  • 14. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U, Naor S, Asnis G, Gasparini F, Goldstein S, Vital-Herne J, Kang BJ.
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract] [Full Text] [Related]

  • 15. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A, Maier W, Holsboer F.
    Psychoneuroendocrinology; 1985 Dec; 10(3):261-71. PubMed ID: 4059474
    [Abstract] [Full Text] [Related]

  • 16. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
    Psychoneuroendocrinology; 1991 Dec; 16(5):375-82. PubMed ID: 1805291
    [Abstract] [Full Text] [Related]

  • 17. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A, Holsboer F.
    Psychoneuroendocrinology; 1986 Dec; 11(2):185-94. PubMed ID: 3018821
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE, Ettigi P.
    Clin Pharm; 1983 Dec; 2(6):538-45. PubMed ID: 6140096
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [Abstract] [Full Text] [Related]

  • 20. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.